Search

Your search keyword '"Ratziu, Vlad"' showing total 60 results

Search Constraints

Start Over You searched for: Author "Ratziu, Vlad" Remove constraint Author: "Ratziu, Vlad" Publisher lippincott williams & wilkins Remove constraint Publisher: lippincott williams & wilkins
60 results on '"Ratziu, Vlad"'

Search Results

2. A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis.

4. A multisociety Delphi consensus statement on new fatty liver disease nomenclature.

5. Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study

7. Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study.

10. Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis.

11. Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score.

13. Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis

14. Liver Stiffness by Transient Elastography to Detect Porto‐Sinusoidal Vascular Liver Disease With Portal Hypertension.

15. Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients

17. Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes.

19. The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials.

21. Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study.

25. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

26. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.

27. Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference.

28. Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science.

29. A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis.

34. Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus.

37. A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis.

Catalog

Books, media, physical & digital resources